Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Franceschini

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Allergy|November 16, 2022
Immediate hypersensitivity reactions to anti-SARS-CoV-2 neutralizing monoclonal antibodies: A real-life experienceLaura Franceschini, Alessandro Farsi
The Lancet. Gastroenterology & Hepatology|August 6, 2022
Eosinophilic oesophagitis and type 2 inflammation multimorbidity: an opportunity for biologic treatmentLaura Franceschini, Alessandro Farsi
The Journal of Allergy and Clinical Immunology|November 9, 2024
IgG4 and eosinophilic esophagitis: Bridging the knowledge gapLaura Franceschini, Alessandro Farsi
The American Journal of Gastroenterology|April 14, 2021
Eosinophilic Esophagitis Onset Despite Six Years' Treatment With Omalizumab in an Asthmatic Patient: No Protective Effect for Anti-IgE Therapy?Laura Franceschini, Raffaele Macchiarelli, Ivano Biviano, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 15, 2023
Eosinophilic esophagitis despite isolated IgG4 deficiency: The still unsolved conundrum of pathogenesisLaura Franceschini, Ivano Biviano, Lara Malaspina, et al.
European Journal of Gastroenterology & Hepatology|October 26, 2020
Eosinophilic esophagitis: is the Th2 inflammation protective against the severe form of COVID-19?Laura Franceschini, Raffaele Macchiarelli, Silvia Rentini, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 1, 2020
Delayed hypersensitivity reactions to edoxabanLaura Franceschini, Giulia Carli, Giancarlo Landini, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 8, 2020
Evaluating nonimmediate cutaneous reactions to non-vitamin K antagonist oral anticoagulants via patch testingGabriele Cortellini, Giulia Carli, Laura Franceschini, et al.
Annals of Vascular Surgery|January 31, 2012
Clinical outcome after extended endovascular recanalization in Buerger's disease in 20 consecutive casesLanfroi Graziani, Luis Morelli, Francesca Parini, et al.
Microorganisms|April 26, 2025
<i>Candida albicans</i> as a Trailblazer for Herpes Simplex Virus-2 Infection Against an In Vitro Reconstituted Human Vaginal EpitheliumFrancesco Ricchi, Stefania Caramaschi, Arianna Sala, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Allergy|November 16, 2022
Immediate hypersensitivity reactions to anti-SARS-CoV-2 neutralizing monoclonal antibodies: A real-life experienceLaura Franceschini, Alessandro Farsi
The Lancet. Gastroenterology & Hepatology|August 6, 2022
Eosinophilic oesophagitis and type 2 inflammation multimorbidity: an opportunity for biologic treatmentLaura Franceschini, Alessandro Farsi
The Journal of Allergy and Clinical Immunology|November 9, 2024
IgG4 and eosinophilic esophagitis: Bridging the knowledge gapLaura Franceschini, Alessandro Farsi
The American Journal of Gastroenterology|April 14, 2021
Eosinophilic Esophagitis Onset Despite Six Years' Treatment With Omalizumab in an Asthmatic Patient: No Protective Effect for Anti-IgE Therapy?Laura Franceschini, Raffaele Macchiarelli, Ivano Biviano, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 15, 2023
Eosinophilic esophagitis despite isolated IgG4 deficiency: The still unsolved conundrum of pathogenesisLaura Franceschini, Ivano Biviano, Lara Malaspina, et al.
European Journal of Gastroenterology & Hepatology|October 26, 2020
Eosinophilic esophagitis: is the Th2 inflammation protective against the severe form of COVID-19?Laura Franceschini, Raffaele Macchiarelli, Silvia Rentini, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 1, 2020
Delayed hypersensitivity reactions to edoxabanLaura Franceschini, Giulia Carli, Giancarlo Landini, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 8, 2020
Evaluating nonimmediate cutaneous reactions to non-vitamin K antagonist oral anticoagulants via patch testingGabriele Cortellini, Giulia Carli, Laura Franceschini, et al.
Annals of Vascular Surgery|January 31, 2012
Clinical outcome after extended endovascular recanalization in Buerger's disease in 20 consecutive casesLanfroi Graziani, Luis Morelli, Francesca Parini, et al.
Microorganisms|April 26, 2025
<i>Candida albicans</i> as a Trailblazer for Herpes Simplex Virus-2 Infection Against an In Vitro Reconstituted Human Vaginal EpitheliumFrancesco Ricchi, Stefania Caramaschi, Arianna Sala, et al.
Pageof 2